Albemarle Corporation
92.70
1.19 (1.30%)
At close: Jan 14, 2025, 3:59 PM
93.07
0.40%
Pre-market Jan 15, 2025, 04:05 AM EST
undefined%
Bid 92.01
Market Cap 10.90B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -16.76
PE Ratio (ttm) -5.53
Forward PE n/a
Analyst Hold
Ask 93
Volume 1,647,761
Avg. Volume (20D) 2,073,667
Open 92.65
Previous Close 91.51
Day's Range 91.54 - 94.70
52-Week Range 71.97 - 143.19
Beta undefined

About ALB

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, hig...

IPO Date Feb 22, 1994
Employees 9,000
Stock Exchange NYSE
Ticker Symbol ALB

Analyst Forecast

According to 21 analyst ratings, the average rating for ALB stock is "Hold." The 12-month stock price forecast is $107, which is an increase of 15.43% from the latest price.

Buy 28.57%
Hold 57.14%
Sell 9.52%
Stock Forecasts

Next Earnings Release

Albemarle Corporation is scheduled to release its earnings on Feb 12, 2025, after market closes.
Analysts project revenue of $1.35B, reflecting a -42.7% YoY shrinking and earnings per share of -0.64, making a -134.59% decrease YoY.
1 month ago · Source
-5.92%
Shares of lithium companies are trading lower. Thi... Unlock content with Pro Subscription
2 months ago · Source
-6.96%
Albermarle shares are trading lower after Keybanc cut its price target on the stock from $132 to $127.